Gibson Dunn | Firm News

Firm News

Our firm, its practices, departments and lawyers receive frequent recognition, ranking us among the world’s best in industry surveys and major publications. We are proud of these honors and believe that they demonstrate the breadth, depth and excellence of Gibson Dunn. We invite you to browse recent news involving our firm.

December 19, 2011

Gibson Dunn Named Leading Tax Law Firm

In the 2012 edition of the Tax Directors Handbook, Gibson Dunn was recognized as a leading tax law firm in France, Germany and the United States.  In addition, the publication named Hatef Behnia to the Tax Directors Handbook 250, a list of the top global tax lawyers as recommended by clients, and it also separately recognized the following tax partners: Dora Arash, Jérôme Delauriére, Ariel Harroch, Paul Issler, Scott Knutson, Arthur Pasternak, David Rosenauer, David Sinak and Jeffrey Trinklein.  
Read More

December 13, 2011

Kelly Austin Receives Asia Women in Business Law Award

At its inaugural Asia Women in Business Law Awards ceremony, Euromoney Legal Media Group named Hong Kong partner Kelly Austin the Best Lawyer in the Corporate Governance category.  The awards ceremony, held on December 8, 2011 at The Hong Kong Jockey Club, recognized leading women lawyers in 19 practice areas and 15 countries.
Read More

December 12, 2011

FDA and Health Care Enforcement Lawyer Joins Gibson Dunn in DC

Gibson, Dunn & Crutcher LLP is pleased to announce Stephen Payne has joined its Washington, D.C. office as a partner.  Payne, formerly a partner at Sidley Austin, will help lead Gibson Dunn’s FDA and Health Care compliance and enforcement practice focusing on pharmaceutical and medical device clients.“We are delighted to welcome Steve to the firm,” said Daniel Nelson, Co-Partner in Charge of the Washington, D.C. office.  “His addition will bring a new dimension to the firm’s enforcement practice and will enhance our ability to serve our clients in the pharmaceutical, medical device and health care sectors.”“Steve is a dynamic and talented lawyer,” said Andrew Tulumello, Co-Partner in Charge of the Washington, D.C. office.  “He has an extensive track record of efficiently obtaining government declinations for clients, and his experience dealing with the FDA and state and federal health care regulators and enforcers on complex regulatory issues will be a great asset to our life sciences practice.”“I am excited to join the firm,” said Payne.  “Gibson Dunn’s preeminent litigation platform is the ideal foundation on which to build an enforcement-focused practice in the FDA and health care space.”About Stephen PaynePayne’s practice focuses on FDA and health care compliance, enforcement, and litigation for pharmaceutical and medical device clients.  He has significant FDA and health care regulatory and compliance counseling experience in the areas of good manufacturing practice regulations, product recalls, product promotion, and fraud and abuse.   He has handled criminal and civil investigations conducted by the FDA Office of Criminal Investigations and the Department of Health and Human Services Office of Inspector General, civil False Claims Act qui tam suits, investigations and litigation conducted by state Attorneys General, and other inquiries and litigation relating to health care fraud and abuse and the enforcement of FDA regulations.  He has also led internal investigations and compliance audits concerning good manufacturing practice regulations and pharmaceutical promotional practices, including potential off-label promotion and anti-kickback issues.Payne has practiced with Sidley Austin since 2000.  Prior to private practice, he served as Senior Trial Counsel for the U.S. Army Judge Advocate General’s Corps at Fort Benning, Georgia and as a Special Assistant U.S. Attorney in the Middle District of Georgia.  He graduated in 1996 from Yale Law School, where he was a John M. Olin Fellow in Law and Economics and a prize finalist in the mock trial competition.
Read More